por 
THE BAJA POST
NEWSROOM
SOURCE: PR NEWSMEDIA
Tampa General Hospital (TGH) today celebrated more than $120 million in charitable contributions over a two-year period to advance its vision to transform health care through innovation. The latest gift toward the $120 million milestone came from the Taneja Family Foundation and is the largest in the foundation’s history.
As part of the celebration, Tampa General leadership, community leaders and members of the Taneja family broke ground on the Taneja Surgical, Neuroscience & Transplant Tower, a medical pavilion in the heart of Tampa Bay, where patients will have access to best-in-class providers, the latest research therapies and state-of-the-art technologies. The tower bears the Taneja name in honor of the Taneja Family Foundation’s contribution to the TGH Foundation.
«Patients come to Tampa General for world-class care, and the addition of this new tower on our campus, thanks in part to the generosity of the Taneja family, enhances our ability to deliver the highest level of academic-based medicine,» said John Couris, president and CEO of Tampa General Hospital. «The Taneja family shares our vision that through innovation, we can transform health care and improve patient outcomes.
The new Taneja Surgical, Neuroscience & Transplant Tower will be an intersection of academics, research and clinical care that will elevate how we are able to treat patients with complex conditions.»
Construction on the Taneja Surgical, Neuroscience & Transplant Tower is expected to be completed in 2027, which will then serve as home for Tampa General’s surgery, neuroscience and transplant service lines. The tower, which consists of a plaza level and 12 floors, will provide 144 patient beds, 32 operating suites and expanded intensive care unit (ICU) capacity. In addition, there will be space for education and training, emergency response and sterile processing, as well as two floors reserved for future growth.
Over the years, Taneja saved enough to bring his wife Manju to the United States. His career spanned from engineering to banking to venture capital. Through the ups and downs, he found ways to support the communities in which they lived and worked, lending his time and talents to benefit causes that were dear to his family. In 2010, Jugal and Manju Taneja together founded Belcher Pharmaceuticals, a company headquartered in Florida that focuses on innovating the development of complex genetic medications and antibiotics.
Tragedy struck the family in 2015 when Jugal and Manju’s son Mandeep was diagnosed with a brain tumor. He passed away in 2018. While Mandeep’s life could not be saved, the Tanejas chose to pay it forward and invest their resources in others in need of specialized care.
